Lipocine (LPCN) stock

Worth $17.6MShares as of Nov 4

$1.59

-7.56%

As of Tuesday's close · Live for Pro members at the open

Not scored

Breakaway doesn't score LPCN. It is too small and too thinly traded for a fair Quality Score.

Healthcare · Pharma

Next2H 2027“results from BLOOM study are expected in 2H 2027”Trial data · SEC filing · Nov 10

Cash$21.5M, about 8 quarters (2 years) at the last year's spendingOn Sep 30

Follow LPCN's trial news. Pro members can get an alert when Lipocine files news, and see its trials, share raises, and its CEO's filings.

Get an alert when LPCN files news on its trialSee it live, free until Thursday morning. No account. No card. Then keep going with a free account.

We do the work for you. 3,168 stocks are scored and ranked, every 15 seconds while the market is open. Pro members see it live.

Cash$21.5M, about 8 quarters (2 years) at the last year's spendingOn Sep 30

What's next for LPCN, and how long its cash lasts

Next step the company has named

2H 2027“results from BLOOM study are expected in 2H 2027”Trial data · SEC filing · Nov 10

What it means: the first look at a trial’s main results, as the company reports them.

A trial underway: BLOOMPhase 3 · Recruiting · 120 people · main data estimated Aug 2027 · NCT07822321

For Pro members: 97 filings.

Cash runway Sep 30 balance sheet

About 8 quarters

$21.5M in cash and short-term investments, at its spending over the last year

What it means: how long the cash would last at the same pace, before any new money.

For Pro members: the cash used each quarter, and the math.

Dilution on the horizon

Shelf registration (S-3, filed Nov 22, 2023)
At-the-market share sales program (424B5, filed Feb 26, 2026)

For Pro members: 2 raises and their amounts, and the share count against a year ago.

Insiders

Director John W. Higuchi bought 25,007 shares on Sep 30. 5 more insider trades this year.

From Form 4: open-market buys and sales only.

Get an alert when Mahesh Patel buys or sells

For Pro members: every trade, and Mahesh Patel’s 16 filings and quotes.

Get an alert when LPCN files news on its trialA free account. No card.

See every upcoming FDA date →

FDA dates in the next 60 days

Decision dates and advisory committee meetings the companies have announced in their filings, soonest first and small companies first.

DateStockDrug

In 12 daysFDA decisionIn 12 days · FDA decisionCAPRCapricor TherapeuticsDeramiocelCAPRCapricor Therapeutics · $500MDeramiocelFDA decision due (PDUFA)
In 12 daysFDA decisionIn 12 days · FDA decisionSVRASavaraMolgramostimSVRASavara · $900MMolgramostimFDA decision due (PDUFA)
In 42 daysFDA decisionIn 42 days · FDA decisionMLYSMineralys TherapeuticsLorundrostatMLYSMineralys Therapeutics · $1.3BLorundrostatFDA decision due (PDUFA)

14 more FDA dates and 103 trial data dates in the next 60 days, each on the FDA calendar. Pro members see whether each company's cash lasts past its date, with an optional alert before it. See all 151 dates, ranked →

LPCN's latest filings

Lipocine Doses First Participant in BLOOM Phase 3 Study of LPCN 1154 for Postpartum Depression8-K, filed Nov 10
Quarterly report10-Q, filed Nov 5
An insider's trade or awardForm 4, filed Oct 1

45 more filings in the last year, for Pro members

From SEC EDGAR, as filed. Each opens the filing on the SEC's site.

Why LPCN isn't scored

The Quality Score reads US-listed stocks worth $50M or more that trade at $1 or more and 300,000 shares or $10M a day. LPCN is worth about $17.6M and trades about 295,000 shares a day. A stock that clears every mark is scored from the next weekly rebuild.

Straight AnswersStraight Answers

Are the prices delayed?

Only on the public pages, which run at least 15 minutes behind. Pro members, and anyone on a guest pass, see real-time prices: the scanner refreshes every 15 seconds, and your watchlist every few seconds, pre-market and after hours included.